{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T04:42:16Z","timestamp":1766983336145,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00467-024-06402-9","type":"journal-article","created":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T01:02:17Z","timestamp":1717203737000},"page":"2969-2977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Daily compared with alternate-day levamisole in pediatric nephrotic syndrome: an open-label randomized controlled study"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0958-616X","authenticated-orcid":false,"given":"Sushmita","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jayati","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiv","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suparna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhankar","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shakil","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitava","family":"Pahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"6402_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","volume":"58","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S et al (2021) Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 58:461\u2013481. https:\/\/doi.org\/10.1007\/s13312-021-2217-3","journal-title":"Indian Pediatr"},{"key":"6402_CR2","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E et al (2023) IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 38:877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3","journal-title":"Pediatr Nephrol"},{"key":"6402_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/ijp.ijp_673_21","volume":"55","author":"GC Bhatt","year":"2023","unstructured":"Bhatt GC, Patel B, Das RR, Malik S, Bitzan M, Mishra NR (2023) Efficacy and safety of levamisole in childhood nephrotic syndrome: a meta-analysis. Indian J Pharmacol 55:43\u201352. https:\/\/doi.org\/10.4103\/ijp.ijp_673_21","journal-title":"Indian J Pharmacol"},{"issue":"4","key":"6402_CR4","doi-asserted-by":"publisher","first-page":"CD002290","DOI":"10.1002\/14651858.CD002290.pub5","volume":"4","author":"NG Larkins","year":"2020","unstructured":"Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM (2020) Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev 4(4):CD002290. https:\/\/doi.org\/10.1002\/14651858.CD002290.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"6402_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO (2021) (2021) clinical practice guideline for the management of glomerular diseases. Kidney Int 100:S1\u2013S276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021","journal-title":"Kidney Int"},{"key":"6402_CR6","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/bcp.12607","volume":"80","author":"AR Kreeftmeijer-Vegter","year":"2015","unstructured":"Kreeftmeijer-Vegter AR, Dorlo TP, Gruppen MP, de Boer A, de Vries PJ (2015) Population pharmacokinetics of levamisole in children with steroid-sensitive nephrotic syndrome. Br J Clin Pharmacol 80:242\u2013252. https:\/\/doi.org\/10.1111\/bcp.12607","journal-title":"Br J Clin Pharmacol"},{"key":"6402_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/bdd.2510070110","volume":"7","author":"E Kouassi","year":"1986","unstructured":"Kouassi E, Caill\u00e9 G, L\u00e9ry L, Larivi\u00e8re L, V\u00e9zina M (1986) Novel assay and pharmacokinetics of levamisole and p-hydroxylevamisole in human plasma and urine. Biopharm Drug Dispos 7:71\u201389. https:\/\/doi.org\/10.1002\/bdd.2510070110","journal-title":"Biopharm Drug Dispos"},{"key":"6402_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13312-014-0419-7","volume":"51","author":"S Ekambaram","year":"2014","unstructured":"Ekambaram S, Mahalingam V, Nageswaran P, Udani A, Geminiganesan S, Priyadarshini S (2014) Efficacy of levamisole in children with frequently relapsing and steroid-dependent nephrotic syndrome. Indian Pediatr 51:371\u2013373. https:\/\/doi.org\/10.1007\/s13312-014-0419-7","journal-title":"Indian Pediatr"},{"key":"6402_CR9","doi-asserted-by":"publisher","first-page":"c137","DOI":"10.1159\/000079172","volume":"97","author":"LS Fu","year":"2004","unstructured":"Fu LS, Shien CY, Chi CS (2004) Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and\/or steroid dependency: comparison of daily and every-other-day usage. Nephron Clin Pract 97:c137\u2013c141. https:\/\/doi.org\/10.1159\/000079172","journal-title":"Nephron Clin Pract"},{"key":"6402_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1007\/s00467-004-1608-8","volume":"19","author":"V S\u00fcmegi","year":"2004","unstructured":"S\u00fcmegi V, Haszon I, Iv\u00e1nyi B, Bereczki C, Papp F, T\u00fari S (2004) Long-term effects of levamisole treatment in childhood nephrotic syndrome. Pediatr Nephrol 19:1354\u20131360. https:\/\/doi.org\/10.1007\/s00467-004-1608-8","journal-title":"Pediatr Nephrol"},{"key":"6402_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.12669\/pjms.36.6.2337","volume":"36","author":"KN Moorani","year":"2020","unstructured":"Moorani KN, Zubair AM, Veerwani NR, Hotchandani HJ (2020) Efficacy of levamisole in children with frequent relapsing and steroid dependent nephrotic syndrome at tertiary care center-Karachi. Pak J Med Sci 36:1193\u20131198. https:\/\/doi.org\/10.12669\/pjms.36.6.2337","journal-title":"Pak J Med Sci"},{"key":"6402_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s13312-017-1144-9","volume":"54","author":"EM Kiruba Samuel","year":"2017","unstructured":"Kiruba Samuel EM, Krishnamurthy S, Bhanudeep S, Muske S (2017) Levamisole in frequently-relapsing and steroid-dependent nephrotic syndrome. Indian Pediatr 54:831\u2013834. https:\/\/doi.org\/10.1007\/s13312-017-1144-9","journal-title":"Indian Pediatr"},{"key":"6402_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1007\/s00467-017-3616-5","volume":"32","author":"AS Abeyagunawardena","year":"2017","unstructured":"Abeyagunawardena AS, Karunadasa U, Jayaweera H, Thalgahagoda S, Tennakoon S, Abeyagunawardena S (2017) Efficacy of higher-dose levamisole in maintaining remission in steroid-dependant nephrotic syndrome. Pediatr Nephrol 32:1363\u20131367. https:\/\/doi.org\/10.1007\/s00467-017-3616-5","journal-title":"Pediatr Nephrol"},{"key":"6402_CR14","first-page":"1753","volume":"31","author":"M Gruppen","year":"2016","unstructured":"Gruppen M, Davin JC, Bouts A (2016) Levamisole increases time to relapse in children with steroid sensitive idiopathic nephrotic syndrome: results of a multicenter double blind placebo controlled randomized control trial [Abstract]. Pediatr Nephrol 31:1753","journal-title":"Pediatr Nephrol"},{"key":"6402_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"MP Gruppen","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC et al (2018) A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney Int 93:510\u2013518. https:\/\/doi.org\/10.1016\/j.kint.2017.08.011","journal-title":"Kidney Int"},{"key":"6402_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.3390\/jcm8060860","volume":"8","author":"AK M\u00fchlig","year":"2019","unstructured":"M\u00fchlig AK, Lee JY, Kemper MJ et al (2019) Levamisole in children with idiopathic nephrotic syndrome: clinical efficacy and pathophysiological aspects. J Clin Med 8:860. https:\/\/doi.org\/10.3390\/jcm8060860","journal-title":"J Clin Med"},{"key":"6402_CR17","doi-asserted-by":"publisher","first-page":"e2350562","DOI":"10.1002\/eji.202350562","volume":"53","author":"GH Khan","year":"2023","unstructured":"Khan GH, Veltkamp F, Scheper M, LEARNS Consortium et al (2023) Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage response. Eur J Immunol 53:e2350562. https:\/\/doi.org\/10.1002\/eji.202350562","journal-title":"Eur J Immunol"},{"key":"6402_CR18","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/0140-6736(91)93257-A","volume":"337","author":"British Association for Paediatric Nephrology","year":"1991","unstructured":"British Association for Paediatric Nephrology (1991) Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet 337:1555\u20131557","journal-title":"Lancet"},{"key":"6402_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/2589-9309.305896","volume":"3","author":"J Singh","year":"2020","unstructured":"Singh J, Afzal K, Abqari S (2020) Daily levamisole versus mycophenolate mofetil in patients with frequently relapsing or steroid-dependent nephrotic syndrome: an open-label non-inferiority randomized controlled trial. Asian J Pediatr Nephrol 3:43\u201348. https:\/\/doi.org\/10.4103\/2589-9309.305896","journal-title":"Asian J Pediatr Nephrol"},{"key":"6402_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-024-06362-0","author":"R Sinha","year":"2024","unstructured":"Sinha R, Sarkar S, Banerjee S et al (2024) Antineutrophil cytoplasmic antibody in children with nephrotic syndrome treated with levamisole: a cross-sectional cohort study. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-024-06362-0","journal-title":"Pediatr Nephrol"},{"key":"6402_CR21","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1007\/s00467-021-05231-4","volume":"36","author":"LA Hoogenboom","year":"2021","unstructured":"Hoogenboom LA, Webb H, Tullus K, Waters A (2021) The effect of levamisole on kidney function in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 36:3799\u20133802. https:\/\/doi.org\/10.1007\/s00467-021-05231-4","journal-title":"Pediatr Nephrol"},{"key":"6402_CR22","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1007\/s00467-022-05547-9","volume":"37","author":"F Veltkamp","year":"2022","unstructured":"Veltkamp F, B\u00f6kenkamp A, Slaats J, Hamer H, Bouts AHM, LEARNS Consortium (2022) Levamisole causes a transient increase in plasma creatinine levels but does not affect kidney function based on cystatin C. Pediatr Nephrol 37:2515\u20132519. https:\/\/doi.org\/10.1007\/s00467-022-05547-9","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06402-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06402-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T15:06:06Z","timestamp":1724771166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06402-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["6402"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06402-9","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"25 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}